Programming implantable cardioverter-defibrillators in primary prevention: higher or later

Nicolas Clementy1, Bertrand Pierre1, Edouard Simeon1

  • 1Cardiology Department, Trousseau Hospital, François-Rabelais University, Tours, France.

Insights

Implantable defibrillator shocks, even appropriate ones, harm quality of life and increase mortality. Optimizing device programming can significantly reduce unnecessary defibrillator shocks in patients with left ventricular dysfunction.

Area of Science:

  • Cardiology
  • Biomedical Engineering

Background:

  • Implantable defibrillators (ICDs) deliver shocks that can cause significant morbidity, including decreased quality of life, depression, anxiety, and increased mortality.
  • Both appropriate and inappropriate shocks contribute to adverse patient outcomes.
  • Inappropriate shocks, unlike other complications, are often preventable through device programming.

Purpose of the Study:

  • To review programming strategies for reducing shock rates in primary prevention ICD patients with left ventricular dysfunction.
  • To discuss device-specific programming considerations across different manufacturers.

Main Methods:

  • Literature review of studies on ICD programming and shock reduction.
  • Analysis of programming techniques aimed at minimizing inappropriate and unnecessary shocks.
  • Examination of device-specific features and recommendations.

Main Results:

  • Adequate ICD programming is crucial for decreasing the rate of inappropriate and unnecessary shocks.
  • Specific programming strategies can mitigate risks associated with defibrillator therapy.
  • Understanding manufacturer-specific settings is key to optimizing patient care.

Conclusions:

  • Optimizing ICD programming is essential for improving patient outcomes and reducing morbidity.
  • Proactive programming adjustments can significantly lower the incidence of shocks.
  • This review provides practical guidance for clinicians managing ICD patients.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.7K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
624